Aller au contenu principal Activer le contraste adaptéDésactiver le contraste adapté
Fermer

Transgene Highlights its Broad Viral Vector Expertise at the Society for Immunotherapy of Cancer (SITC) 2018 Conference
information fournie par Boursorama 07/11/2018 à 18:00

Transgene Highlights its Broad Viral Vector Expertise at the Society for Immunotherapy of Cancer (SITC) 2018 Conference


Strasbourg, France – November 7th, 2018, 6:00 pm CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies, presents its broad viral vector expertise and their potential to transform the fight against cancer at the annual meeting of the Society for Immunotherapy of Cancer (SITC) to be held November 7-11 in Washington DC (USA).

.../...

Valeurs associées

0,6100 EUR Euronext Paris +0,99%

0 commentaire

Signaler le commentaire

Fermer

A lire aussi

Mes listes

Cette liste ne contient aucune valeur.